Cargando…

CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer's Dementia Spectrum

BACKGROUND: According to recent studies, amyloid-β (Aβ) isoforms as cerebrospinal fluid (CSF) biomarkers have remarkable predictive value for cognitive decline in the early stages of Alzheimer's disease (AD). Herein, we aimed to investigate the correlations between several targeted proteomics i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behzad, Maryam, Zirak, Negin, Madani, Ghazal Hamidi, Baidoo, Linda, Rezaei, Ali, Karbasi, Shima, Sadeghi, Mohammad, Shafie, Mahan, Mayeli, Mahsa, Alzheimer's Disease Neuroimaging Initiative
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925239/ https://www.ncbi.nlm.nih.gov/pubmed/36793451 http://dx.doi.org/10.1155/2023/5336273

Ejemplares similares

A Comprehensive Investigation of the Potential Role of Lipoproteins and Metabolite Profile as Biomarkers of Alzheimer's Disease Compared to the Known CSF Biomarkers
por: Nasab, Azam Sajjadi, et al.
Publicado: (2023)

Protective Factors Modulate the Risk of Beta Amyloid in Alzheimer's Disease
por: Zhou, Bin, et al.
Publicado: (2020)

Classification of Alzheimer's and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
por: Nozadi, Seyed Hossein, et al.
Publicado: (2018)

Topological Measurements of DWI Tractography for Alzheimer's Disease Detection
por: Amoroso, Nicola, et al.
Publicado: (2017)

Multimodal MRI-based imputation of the Aβ+ in early mild cognitive impairment
por: Tosun, Duygu, et al.
Publicado: (2014)

Structural Brain Imaging Phenotypes of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Found by Hierarchical Clustering
por: Kärkkäinen, Mikko, et al.
Publicado: (2020)

Tissue-Based MRI Intensity Standardization: Application to Multicentric Datasets
por: Robitaille, Nicolas, et al.
Publicado: (2012)

Frequency Specific Effects of ApoE ε4 Allele on Resting-State Networks in Nondemented Elders
por: Liang, Ying, et al.
Publicado: (2017)

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer's Disease or Mild Cognitive Impairment
por: Li, Lanlan, et al.
Publicado: (2021)

Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease
por: Fleisher, Adam S., et al.
Publicado: (2009)

Standardized quality metric system for structural brain magnetic resonance images in multi-center neuroimaging study
por: Osadebey, Michael E., et al.
Publicado: (2018)

Alterations of the serum and CSF ferritin levels and the diagnosis and prognosis of amyotrophic lateral sclerosis
por: Paydarnia, Parastou, et al.
Publicado: (2021)

Functional Evolving Patterns of Cortical Networks in Progression of Alzheimer's Disease: A Graph-Based Resting-State fMRI Study
por: Li, Wei, et al.
Publicado: (2020)

Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
por: De Velasco Oriol, Javier, et al.
Publicado: (2019)

The Combination of Functional and Structural MRI Is a Potential Screening Tool in Alzheimer’s Disease
por: Huang, Chun-Chao, et al.
Publicado: (2018)

Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease
por: Upadhyaya, Yurika, et al.
Publicado: (2020)

Structural Neuroimaging in the Detection and Prognosis of Pre-Clinical and Early AD
por: Fennema-Notestine, Christine, et al.
Publicado: (2009)

Study of the Influence of Age in (18)F-FDG PET Images Using a Data-Driven Approach and Its Evaluation in Alzheimer's Disease
por: Jiang, Jiehui, et al.
Publicado: (2018)

Isolated schwannoma originating from the infraorbital nerve: A case report
por: Shafie, Mahan, et al.
Publicado: (2022)

Cloud-Based Brain Magnetic Resonance Image Segmentation and Parcellation System for Individualized Prediction of Cognitive Worsening
por: Sakamoto, Ryo, et al.
Publicado: (2019)

Identifying the Alteration Patterns of Brain Functional Connectivity in Progressive Mild Cognitive Impairment Patients: A Longitudinal Whole-Brain Voxel-Wise Degree Analysis
por: Deng, Yanjia, et al.
Publicado: (2016)

A Real-Time Clinical Decision Support System, for Mild Cognitive Impairment Detection, Based on a Hybrid Neural Architecture
por: Suárez-Araujo, Carmen Paz, et al.
Publicado: (2021)

Journey to the other side of the brain: asymmetry in patients with chronic mild or moderate traumatic brain injury
por: Ross, David E, et al.
Publicado: (2023)

Comparison of nine tractography algorithms for detecting abnormal structural brain networks in Alzheimer’s disease
por: Zhan, Liang, et al.
Publicado: (2015)

Late-life obesity is a protective factor for prodromal Alzheimer’s disease: a longitudinal study
por: Sun, Zhen, et al.
Publicado: (2020)

The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson’s disease
por: Shafie, Mahan, et al.
Publicado: (2022)

The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”
por: Mozafar, Mehrdad, et al.
Publicado: (2022)

Psychosis of Epilepsy: A 10-Year Iranian Clinical Survey
por: Shafie, Mahan, et al.
Publicado: (2023)

Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimer's disease
por: Xu, Wei, et al.
Publicado: (2020)

Metabolically healthy obesity reduces the risk of Alzheimer’s disease in elders: a longitudinal study
por: Ma, Ling-Zhi, et al.
Publicado: (2019)

Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent
por: Pascale, Crissey L, et al.
Publicado: (2011)

Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy
por: Lee, Young‐gun, et al.
Publicado: (2021)

CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease?
por: Hu, William T, et al.
Publicado: (2015)

Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
por: Menendez-Gonzalez, Manuel, et al.
Publicado: (2018)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
por: Willemse, Eline A. J., et al.
Publicado: (2021)

Automation vs. Experience: Measuring Alzheimer’s Beta-Amyloid 1–42 Peptide in the CSF
por: Kollhoff, Alexander L., et al.
Publicado: (2018)

Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction
por: Shafie, Mahan, et al.
Publicado: (2021)

Involvement of insulin-degrading enzyme in the clearance of beta-amyloid at the blood-CSF barrier: Consequences of lead exposure
por: Behl, Mamta, et al.
Publicado: (2009)

Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
por: Ewers, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j26i63qq1i4p82ocrcn26rm0qv